Hallux valgus is the most common disease of the forefoot. Its etiology remains unclear, but is influenced by genetics. This condition can cause incapacitating and even disabling problems. It can have several presentations, the clinical and radiological severity of which will guide the treatment.

The level of evidence regarding first-line management remains poor. This article aims to explore the conservative treatment possibilities and their limits, and attempts to provide answers to the questions most frequently asked by patients.

Patients with mild to moderate hallux valgus, or severe hallux valgus, can have their pain relieved without surgical management. It is not yet established that conservative treatment can actually slow down disease progression, but future studies could explore this possibility.

Conservative treatment is based on adapting the footwear, wearing insoles or orthoses, physiotherapy, level I analgesics, as well as lifestyle and dietary adaptations.

In patients who do not respond to conservative treatment and have significant deformity, surgical treatment can be proposed. This treatment yields a satisfaction rate of approximately 80%

Two clinical aspects are discussed this year for the Child and Adolescent Psychiatry Service of the Cliniques universitaires Saint-Luc. They describe the help and care offers implemented to cope with the increase of mental distress situations of children, adolescents, and their families. The first part concerns the deployment of the reference center for Autism Spectrum Disorder, namely the establishment of an early stimulation group for young children awaiting diagnosis and a “parent training” group after diagnosis. The second part encompasses the consolidation of legal time within the SOS-Children team of the Clinics; where we will show the merits and contributions of this specific function in complex cases of child abuse.

During 2022, the ENT department focused on the well-being of the patients in all sub-disciplines of our specialty. First, we were pleased to obtain reimbursement of long-awaited biological products for the treatment of patients with chronic rhinosinusitis with nasal polyps. These new therapies are able to help a significant number of patients whose disease cannot be controlled by standard medical and surgical treatments. Second, we were able to review a series of more than 250 patients who underwent parotidectomy with intraoperative neuromonitoring. We found that preservation of facial nerve function was significantly better compared with previously reported data on parotidectomies without neuromonitoring. Finally, in the field of cochlear implantation for patients with severe hearing loss, we are currently preparing for the future. New techniques have been developed in order to maintain residual hearing during the implant’s insertion into the cochlea, such as robotic surgery and intraoperative electrocochleography. These techniques will allow us to increase the indications for implantation, which will lead to more patients being able to benefit from this life-changing technology.